G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.
about
Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein PhosphatasesSystemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrolThe Multifaceted Roles of PI3Kγ in Hypertension, Vascular Biology, and InflammationAssociation between GRK4 and DRD1 gene polymorphisms and hypertension: a meta-analysisVascular endothelin receptor type B: structure, function and dysregulation in vascular diseasePathophysiology of Heart Failure.Comparative clinical implications of admission electrocardiographic findings for patients with non-ST-segment elevation myocardial infarction.Augmented cardiac hypertrophy in response to pressure overload in mice lacking ELTD1.Molecular basis for small molecule inhibition of G protein-coupled receptor kinasesSurgical Treatment of Cervical Spondylotic Myelopathy Associated Hypertension--A Retrospective Study of 309 Patients.The evolving impact of g protein-coupled receptor kinases in cardiac health and diseaseRegression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.Improvement of vascular insulin sensitivity by downregulation of GRK2 mediates exercise-induced alleviation of hypertension in spontaneously hypertensive ratsCardiac Fibrosis: The Fibroblast AwakensGRK2 in Lymphocytes: Expanding the Arsenal of Heart Failure Prognostics.G-protein-coupled receptor kinase 2 terminates G-protein-coupled receptor function in steroid hormone 20-hydroxyecdysone signaling.Current and future G protein-coupled receptor signaling targets for heart failure therapyGRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms.Hypoxia sensing through β-adrenergic receptors.Role of GRK4 in the regulation of arterial AT1 receptor in hypertension.Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown.G-protein coupled receptor resensitization-appreciating the balancing act of receptor function.Ischemia and reactive oxygen species in sympathetic hyperactivity states: a vicious cycle that can be interrupted by renal denervation?Heart failure-specific changes in protein kinase signalling.Pharmacogenetics of cardiac inotropy.β-adrenergic receptor signalling and its functional consequences in the diseased heart.From Bench to Bedside: New Approaches to Therapeutic Discovery for Heart FailureCalcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.Dual role of GRK5 in cancer development and progression.Association of alpha-ADD1 Gene and Hypertension Risk: A Meta-Analysis.Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation.Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2.Regulation of GPCR expression through an interaction with CCT7, a subunit of the CCT/TRiC complex.Conducting the G-protein Coupled Receptor (GPCR) Signaling Symphony in Cardiovascular Diseases: New Therapeutic ApproachesG protein-coupled receptor kinase 6 is overexpressed in glioma and promotes glioma cell proliferation.A G protein-coupled receptor and the intracellular synthase of its agonist functionally cooperate.Effect of GRK4 genetic variants on blood pressure response to atenolol and cardiovascular outcomes.Paraventricular Nucleus Infusion of Epigallocatechin-3-O-Gallate Improves Renovascular Hypertension.
P2860
Q26776182-BE828595-F3F5-4696-8692-69ECAEA0D87DQ26999376-A6130AF0-7B51-4626-B926-618E64EC7D31Q28066576-BC534722-EB34-4829-824B-C52E96467BACQ28077005-9381D8E9-1F45-4F85-AA7E-190362317234Q28263963-000C0AE0-098C-452B-875A-1EE9603DC7FBQ30315815-453D51D3-43C7-4829-A5B4-5B65CF6EC785Q33595369-755CA936-3B57-43E3-8273-AA31C13AA22EQ34273479-A9764CE0-EC43-4479-8C80-80073EF10EB7Q34992803-158DC702-81E0-4FF4-83A3-D5665C367DA1Q35699909-1DCAB878-ECDE-4987-99BF-49CCB504A8F7Q36000382-8426FE52-8E85-45D5-B34A-406608FB0B08Q36281111-19030674-9526-405E-851D-C5580CBF68B8Q36564011-A4BAF5CE-5327-49A3-94B8-72B2084B8A20Q36708340-FD718B6C-129E-4388-80AD-E10732385786Q36760778-7F80E79C-E852-4198-9B49-40F5690B4727Q37093087-1CFCF987-46E6-43BE-AF46-6BAC826E353BQ37232104-26D22CD7-D10E-4D0C-9839-9C598057CDD9Q37356016-3CC764A2-F4B5-43F3-97BF-B1486607C08AQ37470858-E206440F-C271-44BD-8E17-46BE3285EB46Q37509834-5D2D9C23-A340-4F20-A06C-E3C276EB519AQ37598411-D6883817-4D16-427E-86D6-4A976BFED1F9Q37981274-063A2745-28D6-41CC-94EC-D5CFBA3BDA50Q38018652-0F93F98D-8ECA-48CE-91E5-B2D825B9D7B9Q38113511-4D80FCDB-00CA-4FA8-916C-CE1DF47FC76CQ38186583-1516FFD2-20E9-4EAA-91EE-2BD254F95C7DQ38286038-D2821818-48CD-4480-A366-C4FFD63B8074Q38722030-4AFA0821-7033-4BF9-973C-9595035A46B3Q38780801-29D0A654-F07F-4AC2-9347-B1AC34FFB8EDQ38835689-37955DD9-64DB-4476-815B-27F2BE510791Q38871791-A400DAB2-AABA-490A-BC4C-3AC9CF70DA9DQ38999538-F694795E-4458-415C-923B-482839A8E1D3Q39107039-71AC54F7-D02F-48F6-B20C-315B0B8EBC3AQ39156287-AA095F0A-C3CD-4D31-8B46-435B16F49397Q39345564-B9A591E0-ED97-4984-87DE-4FC3B6EEFB65Q39453304-CCE4B979-2B64-45FB-8CA3-C979B5F24AA5Q41206403-3E9D6CE3-8BA4-4901-8B46-5505BC053F9CQ41552766-9BFFDAD4-A8D2-4656-9713-AF44FEC07B47Q41910497-7B1C8985-60DD-4A29-93F5-AA7532A37130Q43994303-6B7FD72B-55D8-4380-83D7-3BF931E213F4Q46702409-F62E35F8-CD77-49B5-AE18-DDE171A8DF64
P2860
G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.
@ast
G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.
@en
type
label
G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.
@ast
G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.
@en
prefLabel
G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.
@ast
G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.
@en
P2860
P1433
P1476
G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.
@en
P2093
Burns C Blaxall
Stephen L Belmonte
P2860
P304
P356
10.1161/CIRCRESAHA.110.231233
P577
2011-07-01T00:00:00Z